4.7 Article

DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 36, Issue 11, Pages 2318-2327

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2011.120

Keywords

adult ADHD; linkage; genome-wide association; ras pathway; association study; bipolar disorder

Funding

  1. DFG [RE1632/1-1, /1-3, /5, KFO 125, SFB 581, SFB TRR 58, RTG 1252, GR 1912/5-1]
  2. BMBF (IZKF Wurzburg) [01KS9603, IZKF N-27-N]
  3. EC [NEWMOOD LSHM-CT-2003-503474]
  4. Research Council of Norway
  5. Western Norway Regional Health Authority (Helse Vest)
  6. Instituto de Salud Carlos III-FIS, Spain [PI040524, PI041267]
  7. Fundacio La Marato de TV3 [092330/31]
  8. Agencia de Gestio d'Ajuts Universitaris i de Recerca-AGAUR [2009SGR-00971]
  9. 'Ministerio de Ciencia e Innovacion' (Spain)
  10. Hersenstichting Nederland (Fonds Psychische Gezondheid)
  11. Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]
  12. Ministry of Cultural Affairs
  13. Social Ministry of the Federal State of Mecklenburg-West Pomerania
  14. Siemens Healthcare, Erlangen, Germany
  15. Federal State of Mecklenburg-West Pomerania
  16. Janssen BV
  17. Shire
  18. Janssen-Cilag
  19. Eli Lilly
  20. Novartis
  21. AstraZeneca
  22. SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health
  23. Sanofi-Aventis
  24. Siemens AG
  25. Lilly
  26. Medical Research Council [G9817803B] Funding Source: researchfish

Ask authors/readers for more resources

Several linkage analyses implicated the chromosome 9q22 region in attention deficit/hyperactivity disorder (ADHD), a neurodevelopmental disease with remarkable persistence into adulthood. This locus contains the brain-expressed GTP-binding RAS-like 2 gene (DIRAS2) thought to regulate neurogenesis. As DIRAS2 is a positional and functional ADHD candidate gene, we conducted an association study in 600 patients suffering from adult ADHD (aADHD) and 420 controls. Replication samples consisted of 1035 aADHD patients and 1381 controls, as well as 166 families with a child affected from childhood ADHD. Given the high degree of co-morbidity with ADHD, we also investigated patients suffering from bipolar disorder (BD) (n = 336) or personality disorders (PDs) (n = 622). Twelve single-nucleotide polymorphisms (SNPs) covering the structural gene and the transcriptional control region of DIRAS2 were analyzed. Four SNPs and two haplotype blocks showed evidence of association with ADHD, with nominal p-values ranging from p = 0.006 to p = 0.05. In the adult replication samples, we obtained a consistent effect of rs1412005 and of a risk haplotype containing the promoter region (p = 0.026). Meta-analysis resulted in a significant common OR of 1.12 (p = 0.04) for rs1412005 and confirmed association with the promoter risk haplotype (OR = 1.45, p = 0.0003). Subsequent analysis in nuclear families with childhood ADHD again showed an association of the promoter haplotype block (p = 0.02). rs1412005 also increased risk toward BD (p = 0.026) and cluster B PD (p = 0.031). Additional SNPs showed association with personality scores (p = 0.008-0.048). Converging lines of evidence implicate genetic variance in the promoter region of DIRAS2 in the etiology of ADHD and co-morbid impulsive disorders. Neuropsychopharmacology (2011) 36, 2318-2327; doi:10.1038/npp.2011.120; published online 13 July 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available